Abstract
Interleukin-7 (IL-7) is a growth factor for normal precursor B and mature T-cells. We have previously shown that the IL-7 receptor was expressed to varying extent in all cells from a panel of thirteen Burkitt’s lymphoma (BL) cell lines derived from nine children as detected by reverse transcriptase polymerase chain reaction (RT-PCR). The expression in two of 13 BL cells were highly positive, and also detectable by Northern blotting. We therefore investigated the functional significance of this receptor expression. Proliferation of BL cells in the presence and absence of IL-7 was measured by 3H-thymidine incorporation, and by mitochondrial dehydrogenase activity using the MTS color reagent (Celltiter 96AQ, Promega). Apoptosis was measured on cytospins of BL cells by in-situ incorporation of digoxigenin-labeled dUTP into DNA strand breaks using Terminal deoxynucleotidyl Transferase (TdT). Incorporated Dig-dUTP was subsequently detected using an alkaline phosphatase labeled Dig-specific antibody. Apoptosis was also estimated by forward/sides-catter FACS analysis. All proliferation assays were done in serum-free medium. IL-7 inhibited 3H-thymidine incorporation by > 50% only in the three BL cell lines with the highest IL-7 receptor expression. MTS metabolism was inhibited in the same cell lines, but only to a lesser extent of 10–30%. In-situ TdT assays showed no increase in the percentage of apoptotic cells, and the percentage of cell death was not increased on forward/ sidescatter FACS analysis after IL-7 treatment. In contrast to the situation in Burkitt’s lymphoma, control precursor-B-cell ALL lines showed no inhibition, but unchanged or enhanced proliferation. We conclude that IL-7 can be a growth inhibitory cytokine for a subset of BL cells and that induction of apoptosis is not the mechanism of growth inhibition in these cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Smith SD, Rubin CM, Horvath A, Nachman J: Non-Hodgkin’s lymphoma in children. Semin Oncol 17, No. 1: 113, 1990
Smith SD, Rubin CM, Horvath A, Nachman J: Non-Hodgkin’s lymphoma in children. Semin Oncol 17, No. 1: 113, 1990
Magrath I: Malignant non-Hodgkin’s lymphomas in children, in Pizzo PA, Poplack DG (eds): Pediatric Oncology, Philadelphia, J.B. Lippincott Company, 1993, p 537
Heilig B, Mapara M, Bargou R, Fiehn C, Dorken B: TNF alpha therapy activates human B-lymphoma cells in vivo and may protect myelopoiesis. Leuk Res 16: 769, 1992
Taylor CW, Grogan TM, Salmon SE: Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms. Blood 75: 1114, 1990
Yee CS, Messner HA, Minden MD: Regulation of interleukin-6 expression in the lymphoma cell line OCI-LY3. J Cell Physiol 148: 426, 1991
Emilie D, Devergne O, Raphael M, Coumbaras LJ, Galanaud P: Production of interleukin-6 in high grade B lymphomas. Curr Top Microbiol Immunol 182: 349, 1992
Emilie D, Coumbaras J, Raphael M, Devergne O, Delecluse HJ, Gisselbrecht C, Michiels JF, Van-Damme J, Taga T, Kishimoto T, et-al: Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunode¬ficiency virus-seronegative patients. Blood 80: 498, 1992
Henney CS: Interleukin 7: effects on early events in lymphopoiesis. Immunol Today 10: 170, 1989
Chazen GD, Pereira GM, LeGros G, Gillis S, Shevach EM: Interleukin 7 is a T-cell growth factor. Proc Natl Acad Sei U S A 86: 5923, 1989
Touw I, Pouwels K, van Agthoven T, van Gurp R, Budel L, Hoogerbrugge H, Delwei R, Goodwin R, Namen A, Lowenberg B: Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood 75: 2097, 1990
Tomeczkowski J, Beilken A, Frick D, Wieland B, König A, Falk MH, Reiter A, Welte K, Sykora KW: Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt’s lymphoma cells. Blood 86, 1469, 1995
Philip I, Philip T, Favrot M, Vuillaume M, Fontaniere B, Lenoir GM: Establishment of lymphomatous cell lines from bone marrow samples from patients with Burkitt’s lymphoma. JNCI 73 (4): 835, 1984
Wijsman JH, Jonker RR, Keijzer R, van de Velde CJH, Cornelisse CJ, Dierendonck JHV: A New Method to Detect Apoptosis in Paraffin sections: In Situ End-labeling of Fragmented DNA. J Histochem Cytochem41: 7, 1993
Sykora KW, Tomeczkowski J, Kirchhoff K, Yakisan E, Wieland B, Reiter A, Welte K: Expression of the IL-7 receptor and IL-7 induced growth inhibition in childhood Burkitt’s lymphoma cells. Blood 84:159a, 1994 (abstr.)
Benjamin D, Sharma V, Knobloch TJ, Armitage RJ, Dayton MA, Goodwin RG: B cell IL-7: human B cell lines constitutively secrete IL-7 and express IL-7 receptors. Blood 82:241a, 1993 (abstr.)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Sykora, K.W., Tomeczkowski, J., Kirchhoff, K., Yakisan, E., Reiter, A., Welte, K. (1996). Growth Inhibition in IL-7 Receptor Positive Childhood Burkitt’s Lymphoma Cells is not due to Induction of Apoptosis. In: Abraham, N.G., Asano, S., Brittinger, G., Maestroni, G.J.M., Shadduck, R.K. (eds) Molecular Biology of Hematopoiesis 5. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0391-6_24
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0391-6_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8031-3
Online ISBN: 978-1-4613-0391-6
eBook Packages: Springer Book Archive